EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Targeting DNA Damage and Repair Pathways in Cerebral Ischemic Stroke: From Bench to Bedside

Zixian Xie, Yumin Luo, Ziping Han

Translational Stroke Research · 2026-02 · 17 (1)

DOI: 10.1007/s12975-025-01394-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Translational Stroke Research, online erschienen am 05.01.2026. Verfasst von Zixian Xie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beiji…. Hauptthemen laut MEDLINE: DNA Repair, DNA Damage, Ischemic Stroke, Brain Ischemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in reperfusion therapies following cerebral ischemic stroke, effective treatment options remain limited, and achieving optimal outcomes post-revascularization continues to be a significant challenge. Increasing evidences have highlighted the crucial role of DNA damage and its associated downstream inflammatory and apoptotic pathways in the pathophysiology of stroke (collectively known as the DNA damage response, DDR). Enhancing DNA repair has emerged as a promising therapeutic approach to mitigate neural injury and promote function recovery after stroke. This review summarizes recent strategies aimed at neuroprotection through the modulation of DNA damage and repair pathways, focusing on both clinical patients with ischemic stroke and experimental stroke models. Additionally, we explore potential future directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA RepairDNA DamageIschemic StrokeBrain IschemiaNeuroprotective AgentsHumansAnimals

Stichwörter der Autor:innen

DNA damage responseDNA repair enzymesIschemia–reperfusion injuryIschemic strokeMitochondrial DNA

Substanzen

Neuroprotective Agents

Autor:innen und Institutionen

  • Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China.
  • Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China. yumin111@ccmu.edu.cn.
  • Collaborative Innovation Center for Brain Disorders, Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China. yumin111@ccmu.edu.cn.
  • Institute of Cerebrovascular Diseases Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, 45 Changchun Street, Beijing, 100053, China. hanzip@xwhosp.org.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xie, Z., Luo, Y., & Han, Z. (2026). Targeting DNA Damage and Repair Pathways in Cerebral Ischemic Stroke: From Bench to Bedside. Translational Stroke Research, 17(1). https://doi.org/10.1007/s12975-025-01394-6

Vancouver

Xie Z, Luo Y, Han Z. Targeting DNA Damage and Repair Pathways in Cerebral Ischemic Stroke: From Bench to Bedside. Translational Stroke Research. 2026;17(1). doi:10.1007/s12975-025-01394-6

BibTeX
@article{Xie2026,
  author = {Xie, Zixian and Luo, Yumin and Han, Ziping},
  title = {Targeting DNA Damage and Repair Pathways in Cerebral Ischemic Stroke: From Bench to Bedside},
  journal = {Translational Stroke Research},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12975-025-01394-6}
}
Kostenlos starten →